Thava Palanisami
This study provides important new evidence that micro- and nanoplastics can be detected in the coronary circulation of patients experiencing heart attacks and are associated with higher levels of inflammation and environmental exposures such as air pollution and smoking. While the findings do not prove that plastics directly cause heart attacks, they strengthen the growing scientific evidence that plastic pollution is an emerging public health issue deserving serious attention.
Although the authors implemented rigorous contamination controls, measuring micro- and nanoplastics in blood remains technically challenging. There is still no internationally standardised method for sampling, extraction, identification and quantification, making comparisons between studies difficult. In addition, current analytical methods cannot fully characterise the smallest nanoplastics (<1 µm), which may have different biological behaviour. Another limitation is that the study measured the presence of plastic polymers but did not distinguish whether the observed biological effects were caused by the particles themselves, the chemicals they carry, or co-exposure to other environmental pollutants such as air pollution and tobacco smoke. The finding that smoking was the only independent predictor of microplastic detection in multivariable analysis highlights the complexity of separating these environmental exposures.
The study highlights the need for larger, long-term human studies to determine whether reducing exposure to micro- and nanoplastics can lower the risk of cardiovascular disease. Given the widespread presence of plastics in our food, water and air, we need coordinated action to reduce unnecessary plastic pollution, improve human exposure monitoring, and accelerate research into the health impacts of plastics. Protecting people from plastic pollution should become a key component of future environmental and public health policy.
Overall, this study is an important step forward, but much larger prospective studies with harmonised analytical methods and detailed exposure assessment are needed before firm conclusions can be drawn about the causal role of micro- and nanoplastics in cardiovascular disease.